Abstract
Introduction: A simple, sensitive and reliable sensor has been explored for the determination of Melatonin (MEL) using cyclic voltammetry (CV) and square wave voltammetry (SWV).
Method: Irreversible oxidation of MEL was found to proceed through an adsorption controlled pathway at the glassy carbon electrode. The quantitative estimation of MEL was performed using SWV in a linear concentration range of 5-200 µM with a sensitivity of 0.0437 µM/ µA and a limit of detection of 0.3432 µM. The proposed protocol was also applied for determining MEL content in pharmaceutical samples and recovery studies in human urine samples were also performed.
Result: The observed results demonstrated a good agreement with the stated values.
Keywords: Melatonin, glassy carbon electrode, voltammetry, oxidation, human urine.
Current Pharmaceutical Analysis
Title:Electrochemical Behavior of Melatonin and its Sensing in Pharmaceutical Formulations and in Human Urine
Volume: 13 Issue: 1
Author(s): Neeraj Kumar and Rajendra N. Goyal
Affiliation:
Keywords: Melatonin, glassy carbon electrode, voltammetry, oxidation, human urine.
Abstract:
Introduction: A simple, sensitive and reliable sensor has been explored for the determination of Melatonin (MEL) using cyclic voltammetry (CV) and square wave voltammetry (SWV).
Method: Irreversible oxidation of MEL was found to proceed through an adsorption controlled pathway at the glassy carbon electrode. The quantitative estimation of MEL was performed using SWV in a linear concentration range of 5-200 µM with a sensitivity of 0.0437 µM/ µA and a limit of detection of 0.3432 µM. The proposed protocol was also applied for determining MEL content in pharmaceutical samples and recovery studies in human urine samples were also performed.
Result: The observed results demonstrated a good agreement with the stated values.
Export Options
About this article
Cite this article as:
Kumar Neeraj and Goyal N. Rajendra, Electrochemical Behavior of Melatonin and its Sensing in Pharmaceutical Formulations and in Human Urine, Current Pharmaceutical Analysis 2017; 13 (1) . https://dx.doi.org/10.2174/1573412912666160422154459
DOI https://dx.doi.org/10.2174/1573412912666160422154459 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A
Recent Patents on CNS Drug Discovery (Discontinued) The Gender Bender effect in Periodontal Immune Response
Endocrine, Metabolic & Immune Disorders - Drug Targets High-Throughput Structural Biology in Drug Discovery: Protein Kinases
Current Pharmaceutical Design Opioid Ligands Having Delayed Long-Term Antagonist Activity: Potential Pharmacotherapies for Opioid Abuse
Mini-Reviews in Medicinal Chemistry Tension Type Headache
Current Rheumatology Reviews Electroencephalography and Dementia: A Literature Review and Future Perspectives
CNS & Neurological Disorders - Drug Targets Uric Acid and Oxidative Stress
Current Pharmaceutical Design TRP Channels and Pain
Current Pharmaceutical Design Adrenergic and V1-ergic Agonists/Antagonists Affecting Recovery from Brain Trauma in the Lund Project Act on Astrocytes
Current Signal Transduction Therapy Meet Our Editorial Board Member
Current Alzheimer Research Neurotoxicity of Insecticides
Current Medicinal Chemistry Aldehyde Oxidase Activity and Inhibition in Hepatocytes and Cytosolic Fraction from Mouse, Rat,Monkey and Human
Drug Metabolism Letters A Probable Topiramate-induced Limbs Paraesthesia and Rigid Fingers Flexion
Current Drug Safety Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review
Recent Patents on Drug Delivery & Formulation Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research IDO and Clinical Conditions Associated with Depressive Symptoms
Current Drug Metabolism Challenges of Stem-cell-based Craniofacial Regeneration
Current Stem Cell Research & Therapy Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy Role of Synovial Fibroblasts in Rheumatoid Arthritis
Current Pharmaceutical Design Borderline Personality Disorder in Adolescents
Adolescent Psychiatry